Trending Now
IVERIC Bio Inc (NASDAQ: ISEE) Announces License Agreement With DelSiTech Ltd...
IVERIC Bio Inc (NASDAQ: ISEE) has announced a global license agreement with DelSiTech Ltd, which will offer Iveric Bio the right to create and...
Viking Therapeutics stock (VKTX) could hit all time high and here’s...
Viking Therapeutics, Inc. (VKTX), a clinical-stage biopharmaceutical company, is making significant strides in its pipeline of treatments for obesity, liver diseases, and...
Pieris Pharmaceuticals ($PIRS) and Palvella Therapeutics Announce Exciting Merger
Big news in the world of rare genetic skin diseases—Pieris Pharmaceuticals Inc. (NASDAQ: PIRS) and Palvella Therapeutics have announced their merger. This...
Popular News
The Cannabis Election Run Has Started (GRWG, CURLF, CBGL, TCNNF)
Senator Kamala Harris – running mate on the Joe Biden presidential ticket – confirmed our thesis in her debate with vice president Pence last...
MAKE IT MODERN
LATEST REVIEWS
Cogent Biosciences Inc (NASDAQ: COGT) says The Ongoing Phase 2 APEX...
Cogent Biosciences Inc (NASDAQ: COGT) has unveiled details related to its ongoing Phase 2 APEX clinical trial. It was a trial that targeted the...
MAKE IT MODERN
PERFORMANCE TRAINING
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) Receives Marketing Authorization For Firdapse To Cure Patients With LEMS:...
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) received marketing authorization for Firdapse from Health Canada to treat patients with LEMS (Lambert-Eaton myasthenic syndrome) in Canada.
Marketing authorization under...
Addentax Group Corp (NASDAQ:ATXG) is surging and could continue here’s why
Addentax Group Corp. (NASDAQ:ATXG) is currently trading at $5.95 up+1.87 (+45.83%). ATXG currently has a 52 week range of $3.81 - $656.54....
ALX Oncology Holding Inc. (NASDAQ: ALXO) Receives Orphan Drug Designation for Evorpacept in Gastric...
ALX Oncology Holding Inc. (NASDAQ: ALXO) has announced that the US FDA has granted its next-generation CD47 blocker, evorpacept an orphan drug designation for...
Could this Small Food Delivery Start-Up be Lined up for Acquisition Interest? (TWOH, UBER,...
Acquisition potential is a major factor driving capital allocation. One space that has started to show signs of a potential wave of...
Cardiff Oncology (NASDAQ:CRDF) Reports Its Q3 2020 Financial Results And Onvansertib Development Updates
Cardiff Oncology (NASDAQ:CRDF) has announced its financial results and business highlights for the three months ended September 30, 2020.
Cardiff presents onvansertib data on KRAS-mCRC
Dr...
MAKE IT MODERN
